+ All Categories
Home > Documents > An international, fullservice RO that specializes in …€¦ ·  · 2017-07-03NGS, Incorporated...

An international, fullservice RO that specializes in …€¦ ·  · 2017-07-03NGS, Incorporated...

Date post: 06-Apr-2018
Category:
Upload: hoangdang
View: 219 times
Download: 3 times
Share this document with a friend
16
In Operaon Since 198458 Approved Products—Zero 483s Clinical Operaons and Monitoring Trial Rescue Risk Based Monitoring Paent Reported Outcomes (ePRO) Clinical Call Center-Screening, Recruitment and Safety Data Management and EDC IWRS—Fully integrated into EDC Plaorm Trial Masterfile (eTMF) CTMS Management Medical Monitoring / Safety Management Grants , Contracts and Site Payment Quality Assurance Regulatory Compliance Global Strategic Sourcing Medical Wring Biostascs Pharmacovigilance NCGS Inc., 288 Meeng Street, Suite 400, Charleston, SC 29401 (843) 722-8330 www.ncgs.com An internaonal, full-service CRO that specializes in conducng and managing clinical trials.
Transcript

In Operation Since 1984—58 Approved Products—Zero 483s

Clinical Operations and Monitoring

Trial Rescue

Risk Based Monitoring

Patient Reported Outcomes (ePRO)

Clinical Call Center-Screening, Recruitment and Safety

Data Management and EDC

IWRS—Fully integrated into EDC Platform

Trial Masterfile (eTMF)

CTMS Management

Medical Monitoring / Safety Management

Grants , Contracts and Site Payment

Quality Assurance

Regulatory Compliance

Global Strategic Sourcing

Medical Writing

Biostatistics

Pharmacovigilance

NCGS Inc., 288 Meeting Street, Suite 400, Charleston, SC 29401

(843) 722-8330 www.ncgs.com

An international, full-service CRO that specializes

in conducting and managing clinical trials.

NCGS, Incorporated is an international full-service CRO, providing clinical development support to Pharmaceutical, Biotechnology, Medical Device and Diagnostic companies. NCGS’ business model is discernibly different than industry standard: Utilizing highly tenured staff, NCGS consistently delivers studies on time, within budget and of the highest quality. NCGS is a WBENC certified Diversity Supplier, has been in operation for over 30 years and supported the approvals or expanded labeling of 58 products with zero 483s.

NCGS understands that the CRO-Sponsor relationship is one of shared vision, complementary expertise and trust. NCGS’ team understands the demands of the life science industries, seeking ways to make each clinical effort more quality based, thorough, timely and cost-effective.

NCGS’ mission is to protect research subjects, capture quality data and maintain the integrity of science with the same passion one would protect their own domain. Each staff member is charged to function under the mantra, “This product could easily be used on your parent, sibling, or yourself.” “It is not only our hope for this product, it is the world’s hope for this product.”

NCGS’ Quality Performance and Discernible Difference:

In operation since 1984

58 approved products

Zero FDA 483s

CRA Average Experience - greater than 10 years

Turnover Rate- 3%

Diversity Supplier- Women Business Enterprise National Certification

Several former clients are currently NCGS staff

Service Offerings

Clinical Operations and Clinical Monitoring

Trial Rescue

Clinical Call Center– Screening, Recruitment and Safety

Data Management, EDC

IWRS—Fully integrated to EDC Platform (eliminating duplicate license fees)

eTMF and CTMS Management

Medical Monitoring and Safety Management

Grants, Contacts, Site and Vendor Payment

Regulatory Compliance and Quality Assurance

Global Strategic Sourcing

Medical Writing

Biostatistics

Phamacovigilance

Ex-US Regulatory Affairs

Global Footprint

US, Canada, and EU (Latin America, Australia, Asia- Pacific including India through col-laborations)

NCGS Overview

ncgs.com

NCGS has a proven quality track record with over 30 years of clinical operational excellence with zero 483s. Sponsor challenges and pain points are addressed with “First in Class” research professionals. Many NCGS field and management professionals were previous NCGS clients. Several staff held site management positions early in their careers, providing them with insight into creative site management for a productive study outcome.

Clinical Operations Staff

Experience– Greater than 10 years tenure on average

Cross-functional expertise

Monitoring and Project Management

Regulatory Due Diligence and GCP/ICH Compliance

Auditing

Strong Clinical Data Management Interface

65% have Director and Global Director Experience

Available under FSP or Full Service

Employ Clinical CAPA (Corrective and Preventative Action) In-Process

Functional Flexibility

Back-Up- Each assigned position has an assigned back-up

Back-up strategy is employed from study onset, not implemented emergently

Absence of attrition and solid clinical development knowledge

Key elements to ensure site performance and relationship success.

Functional and Interactive consistency is achieved employing strategic back-up model - Cross team and site communications highly effective with tenured staff

Continuity breeds quality results and site satisfaction

Consistently delivering studies on time, on budget and with the highest quality

Superior results with an elite development team that functions strategically

24/7/365 call center ensures ready access for clinical, regulatory and safety inquiries

Communication Through Diverse Methods: Avoid “Sea of Sameness”

Relationship strength is communication based beyond weekly CRA Contacts

Medical Monitor monthly rotations and monthly “call” notations

Sponsor Updates: Metrics, early obstacle identification, intervention successes

Site Contingency Plans: Define / Employ / Mitigate Risk

Investigator Teleconferences

Newsletters, FAQs, Email Blasts

Clinical Operations and Monitoring

ncgs.com

Strategic Subject Recruitment—Therapeutic Drivers

Referral(s): Physicians, hospital units, clinics, free clinics, urgent care clinics

Media / Internet: Clinical Trial Website, Therapeutic Website, Site Website

Secure Sponsor/NCGS Web Portal

Create self-referral opportunities– Poster, fliers, ads, support groups

iPad and iPhone free applications

Social Media: future (Twitter Guidance)

Subject Retention

Plan > Outline > Remind > Modify > Caregiver considerations

Electronic and manual recall tools

Direct Subject Alerts—HIPAA Compliant

Electronic reminder via phone or internet

Evaluability

Train and re-train

Compliance management

Query discussion and teaching tool

Avoid repeat errors

Grant payments > fiscal impact deviations > motivation escalates performance

Open Payment Act Compliance

Quality Based Management Standards

Quality Plan / Project Management Plan

Assumptions and Deliverables

Metric Based

Patterns of Errors – Early Detection

Continuous Improvement

Clinical CAPA (Corrective and Preventive Actions) In-Process

Timelines, Milestones, Resource Allocation

Tools, Report Formats

Risk Mitigation Plan

Performance Assessments

Obstacle Identification

Root Cause Analysis

Intervention Success

Communication Plan and Issue Escalation

Senior Management Oversight

Clinical Operations and Monitoring

ncgs.com

Risk Based Monitoring

Trends in Remote Monitoring and/or Risk Based Monitoring

Quality enterprise—GCP/ICH E6/FDA compliant remote monitoring practices

Subject Safety Enhanced—Immediate review

Data Quality and Integrity Improved—Data patterns emerge

Critical Parameters—I/E; ICF; Endpoints; safety/SAE; D/C reason; extra tests; adjudication; blinding; accountability

Source Upload de-identified critical source data

Monitoring Plan—Identify methods, rationale and detail of processes

On Site Monitoring—Critical at study onset; sites at risk; study complexity driver, data outliers

Deviation tracking—Root cause analysis

Remote Monitoring Documentation—Activity date; summary of data reviewed; noncompliance; action plan

Fiscally responsible with quality outcome

Patient Reported Outcomes

Listen to the Patient and Caregiver

Communicate the patient perspective

Strategic study design details

Value messages specific to patient population

Measures strategically support product approval/labeling, reimbursement

Validated tools—adaptable, reliable (minimal user-user variability)

Compliance mapping indicators

Establish clinically meaningful change

Strategic post-marketing product value

Subject Retention—Plan > Outline > Remind > Modify > Caregiver Considerations

Electronic and Manual Recall Tools

Direct Subject Alerts—HIPAA Compliant

Clinical Operations and Monitoring

ncgs.com

NCGS provides sponsors with quality data management services. EDC, IWRS and CTMS systems are fully integrated. All systems are fully validated, 21 CFR part 11 compliant electronic data capture solutions that are capable of handling small, single site Phase I trials up to multi-national, multi-lingual Phase III and IV trials.

Data Management Plan Development

EDC Solution: Medidata Rave and Merge eClinical OS

Web-based solution with scalability

Accessible through any web-enabled device including mobile platforms

Fully integrated EDC, IWRS and CTMS solution

Adjudication module

Clinical image management

External data uploads and verification

Missing results reports

Edit specifications - CDISC standards

Coding - Adverse Events (MedDRA) and Medications (WHO Drug)

SAE Reconciliation

Source data uploads

Risk based monitoring capable

Compelling pricing structure

User fees based on sites and trial duration, not annual fees

Database Closure/Lock

Rapid subject “cleaning” and datalock– 5 days last monitoring visit

Legacy Experience Other EDC and Data Management Systems

Inform, MediData, Oracle RDC, ClinTrial

IWRS

Randomization

Fully incorporated into EDC user’s flow

One time fee at study initiation

No ongoing duplicate user fees

Automatic database validations to ensure patient eligibility

Auto-population of randomization information onto eCRFs for data review

Drug Supply

Bulk v. unique drug supply

Inventory management

Expiration management

Custom reports

Automatic email notifications

Data Management, EDC and IWRS

ncgs.com

NCGS will establish and maintain your trial master file in audit ready compliance with our robust and expanding TMF/eTMF centralized team of more than 100 experienced regulatory document specialists and regulatory associates. NCGS’ e-TMF preferred solution meets global regulatory compliance requirements (GCP, ICH E6, FDA, 21 CFR Part11 / EU Annex 11 compliant, EMEA, etc.) and follows the hierarchy and indexing standards from DIA’s TMF Reference Model which is an extension of the EDM Reference Model addressing standards for electronic submissions. NCGS has proven talent regarding audit readiness as evidenced during our most recent FDA audit 27FEB-1MAR 2012 for an international infectious disease trial resulting in zero findings.

TMF/eTMF Sponsor Drivers - Establishing or Merging TMFs/eTMF:

Launch of a new compound

Acquisition of a company or compound and need to merge critical TMF documents

Joint development effort

Acquisition of a new eTMF system requiring resources for consolidation efforts

TMF centralization efforts requiring a preferred TMF or eTMF vendor

Access, Security and Achieving Compliance:

Web-based secure centralized access to CRO and stakeholders

Decreases regulatory start-up time and review processes

Eliminates duplication of resources and multiple back-up paper repositories

Improves ongoing document reconciliation

Provides document capacity to meet global trial management needs

Regulatory compliance

CFR Part 11 compliance (limited access, password protected, audit trails, date and time stamps)

Accuracy, completeness and legibility

Certified - employing a validated QC process

Records are enduring and available when required

Provides standard reports - missing and incomplete documents with visual indicators

Provides a competitive advantage to stakeholders in providing evidence of GCP and of the trial’s overall scientific credibility

Risk Mitigation Noncompliance

Demonstrate compliance of the investigator, sponsor and monitor with the standards of good clinical practice (GCP) with all applicable global regulatory requirements

Standardizes processes for ensuring document compliance

Predefines list of expected documents for every trial based on specific study characteristics

Decreases complexity of maintaining required FDA regulatory documents by streamlining the creation, collection, management and storage of critical clinical research documentation

Image and indexing quality checks

Reports against client-defined milestones; expected versus actual

Clarifies picture of incomplete or overdue documents

eTMF and CTMS Management

ncgs.com

Benefits: Rapid start-up Wizards - Simplify design processes (quick and repeatable) No additional capital equipment outlay or investment by sponsor Native MS Office and Adobe PDF support Rapid QA process Unique trial-based or compound-based user licensing model Email-like interface Metrics

Planned versus actual milestones Decreases audit preparation time Customizable reports, views and document sub-type Reduces expensive redundant storage requirements Eliminates paper handling, paper storage and fire and security expense Managers no longer need to produce off-line tracking spreadsheets

Configurable detailed reports by site, study, compound Case Study: NCGS merged worldwide documents for 200 ongoing trials for one of the largest Pharma companies in the industry. Merging historical documents into one central system in the presence of ongoing trials from fifteen (15) different repositories and alternate system types is a complex operation. NCGS’ Discernible Difference and Competitive Advantage: Robust regulatory compliance staff with years of previous experience in essential

document processing during trial launch Staff is fully versed in document quality control standards, document conversion, critical

adherence to specified naming conventions and electronic transfer from multiple formats or environments

NCGS can manage your eTMF in our eTMF electronic preferred platform or your preferred platform

NCGS can provide this level of expertise at costs substantially less than our global competitors

NCGS’ eTMF preferred solution provide stakeholders evidence of GCP compliance and a clinical trial’s overall scientific credibility

eTMF and CTMS Management

ncgs.com

NCGS medical monitors have medical practice and clinical research experience which leads to an understanding of site challenges and resolution recommendations. Therapeutic expertise is provided by board certified in-house physicians in key therapeutic areas. Medical monitors are familiar with key opinion leaders (KOL) and high-enrolling sites. They drive physician to physician communication with 24/7/365 coverage.

Medical Monitoring and Compound Development Services

Compound development plan

Statistical analysis plan review

Clinical data capture plan review

Investigator site selection input

Protocol training / PI meeting

Call center site support 24/7/365 and language translation services

Interaction with regulatory agency

Protocol development

Safety Management Services

Eligibility and safety assessments

Safety management plan

Data safety monitoring board

Safety data capture plan

Data Safety Charter

Protocol safety section

Reconcile safety and clinical databases

Distribution of expedited reports to PI/IRBs

Safety Reporting Services

Clinical study reports

Abstracts and manuscripts

SAE report review

Safety narratives

Safety legacy database integration

Coding – MedDRA (or sponsor)

Data safety listings and reports

Annual reports

Medical Monitoring / Safety Management

ncgs.com

Rapid Study Start-Up

Rapid contract execution from site qualification visit

NCGS contract processes employ efficiency in language and budget negotiation

Standard acceptable changes identified at study initiation and updated as language negotiations are accomplished

Discovery of any obstacles to contract full execution at individual sites

Discovery of any site contract language mandates that may assist sponsor legal prior to receipt of contract comments (i.e., indemnification agreements, third party agreements, investigator fraud clauses, etc.)

Alerts for revisions driven by enrollment feasibility questionnaire information that may provide insight into site processes and mandates

Timeline, order and impact of contract verses IRB approvals researched to determine if site can meet study initiation target dates

Payments tied to Evaluability Metrics

Quality driven payment structure

Feedback to the site is provided for each subject payment and incremental decrease of full payment is employed for evaluations the site fails to perform

Feedback and payment reductions lead to site realization (cause and fiscal effect) of sub-quality performance impact

NCGS payment method eliminates improper incentives for non-performance which is a growing agency concern

Fiscal accountability shifted to the site for study related procedures drives study compliance metrics and evaluability

Evaluability Shifts

In previous trials where NCGS has rescued the study - grant savings of $250,000 have been realized due to improved evaluability

Quality performance of NCGS initiated trials avoids needless lost grant fees due to focused subject management and close fiscal review of payments

NCGS’ payment process offers sites efficient and expeditious payment turnaround

CRF in-house and reviewed clinically and for payment within 24 hours

Eliminates duplication of effort between clinical and contract payment group

Reasonable fund retains are held until query resolution accomplished

Open Payment Compliance

Site Satisfaction

Payment efficiencies lead to investigator and site satisfaction

Grants, Contacts and Site Payments

ncgs.com

NCGS recognizes the importance of quality initiatives in all aspects of research. The Quality Management Plan is the cornerstone of all development efforts ensuring regulatory compliance and quality deliverables.

Quality Management Plan / CAPA (Corrective and Preventative Actions)

Development of standards of operations to achieve a quality-based system

Applicable regulations addressed

Identify quality and efficiency objectives

Clear delegation of responsibilities

Root cause analysis

Implementation of quality-based standards of operations

Resource allocation and training

Define metrics to measure efficiency

Define preventive measures to avoid common areas of non-compliance

Communication algorithm and issue escalation

Plan for assessing effectiveness of any interventions or preventative methods

Maintenance of quality-based standards of operations

Assess defined and collected metrics for quality performance

Employ intervention when required and test efficiency of intervention

Root cause analysis (RCA) and proper “Action Plan”

Documentation and evaluation of quality-based standard of operations

Define the level of documentation required to assess quality performance

Define the frequency of documentation to assess quality performance

Assess effectiveness of any intervention or preventative measures

Process approach to meet objectives

Anticipated outcomes defined

Mitigating risks and consequences

Focus on prioritized improvement opportunities

Factual approach to decision making

Effective decisions are based on analysis of data and information

Continuous improvement

Conduct audits - contracted and internal

Cost effective system to meet objectives

Host sponsor audits and regulatory authority inspections

All of these activities provide:

Input into improving NCGS’ quality processes

Assurance of regulatory compliance

Fiscal responsibility

Quality Assurance & Regulatory Compliance

ncgs.com

NCGS global strategic sourcing solution is a hybrid model offering a customized balance of our Strategic Sourcing staffing capabilities with or without engaging our full service CRO. Strategic Sourcing provides individuals or functional teams or multi-disciplinary teams tailored around our client’s specific requirement(s).

Customized Solutions to Resourcing Needs

Individual contract placement or permanent placement

Interim/Short-term solutions for peak periods and special projects

Teams developed - Functional areas, partial or full teams

Dedicated staff for duration of client need / sourcing allocation

Seamlessly expand limited resourcing to full service sourcing or any hybrid solution required

Benefits of Strategic Sourcing

Significant cost reduction compared to a fully outsourced study

Reducing employment risks

Increasing ability to meet project deadlines and peak periods of activity

Maintaining smooth operations when staffing needs to fluctuate

Flexible Billing Models

Hours worked including travel if partial or fluctuating FTEs are required

Per FTE for the specific duration of the assignment

Billing frequency and format is negotiated in MSA

All reasonable pass-through expenses will be agreed upon in the MSA

Operational Gaps

NCGS provides clinical research professionals across a broad range of job functions with significant industry experience, in a wide variety of therapeutic areas. Our personnel can be located at your office, NCGS office or regional field based positions. Service areas include:

Choosing NCGS Strategic Sourcing

Staff turnover (<3%) due to high employee satisfaction

NCGS tailors team processes to match client standard of operation

NCGS provides highly tenured staff

Sponsor has first right of access to re-assign staff members to another project benefiting from corporate intelligence

Therapeutic Concentrations in Complex Arenas - Oncology, Hematology, CNS, Infectious Disease, Cardiology, Pulmonary, etc.

Clinical Management Medical Monitoring Biostatisticians

Site Monitoring Drug Safety Data Management

Site Recruitment / Start-Up Medical Writers CTMS Management

Site Study Coordinators Quality Assurance Staff Training

Grant and Contracts * eTMF Management Regulatory Affairs

Global Strategic Sourcing

ncgs.com

NCGS provides sponsors with the highest possible quality of standards-compliant, scientific documentation and medical writing services to the medical research community. Documentation is clear, concise and scientifically accurate with format and content in strict accordance with regulations and guidance.

➢ Clinical Operations Staff

➢ Protocols

➢ Investigator Brochures

➢ Clinical Sections of Regulatory Filing Documents including:

Clinical study reports (Full ICH or FDA-Abbreviated)

Integrated summaries of efficacy and safety

Module 2 of the common technical document

➢ Full Template Support to Ensure FDA, ICH, and Sponsor Compatibility

➢ Abstracts

➢ FDA Briefing Materials

➢ NDAs in CTD format

➢ Journal Publications and Scientific Presentations

➢ Risk Evaluation and Mitigation Strategy (REMs)

Medical Writing

ncgs.com

NCGS provides sponsors with the highest possible quality of statistical support services to the medical research community.

Clinical Development Services

Design and Related Statistical Consulting for:

Pre-clinical and clinical (Phases I-IV) trials

Toxicity, pharmacokinetic/dynamic, and generic equivalence

Analysis of results for IDE, NDA, ANDA, PMA and 510(k) submissions

Assistance with Strategic Preparation for FDA Meetings

Established contacts with FDA personnel

Representation at FDA/Sponsor Meetings

Knowledgeable of eCTD Structure and Components:

Required versus optional elements and structure granularity

Conventions (fonts, sizes, versioning, file names, leaf elements)

Experienced in building eCTDs and producing eCTD components

Documents: Modules 2,5, ISE, ISS

SAS XPT files: 1999 Guidance (Raw[Listing] and Analysis)

CDISC (Clinical Data Interchange Standards Committee)

• SDTM (Study Data Tabulation Model)

• ADaM (Analysis Data Model)

Documentation: define.pdf and define.xml

SAS programs

Biostatistical Services

Protocol Development, Statistical Design and Statistical Modeling

Sample Size Determination

Generation of Randomization Codes

Statistical Programming and Analyses:

Tables, figures, listings

Patient profiles

Integrated efficacy and safety databases

Independent Statistical Team for Interim Analyses & DSMB

Data Transfer

Biostatistics

ncgs.com

Patient safety is of paramount importance in every clinical trial. Individualized safety management and reconciliation plans are developed for each study. NCGS provides sponsors with the highest possible quality of global Pharmacovigilance services to the medical research community.

➢ Global Safety Database

Hosted client specific global solution (ARISg)

Remote entry of cases in sponsor global safety database

➢ Comprehensive Safety Management Plans (SMPs)

Including MedWatch and CIOMS reporting

➢ Clinical Trials and Post Marketed Products

➢ Expedited Electronic Reporting to EudraVigilance System

➢ Paper Based Reporting

Investigators, Ethic Committees and National Authorities

➢ Annual and 6 Monthly Aggregate Trial Safety Reporting

➢ Preparation/Submission of Aggregate Safety Reports (PSUR/PADER)

➢ Signal Detection

➢ Global Literature Searches (Retrospective/Prospective)

➢ Legacy Data Upload Projects

➢ Medical Coding

➢ 24/7 Safety Call Center with Language Translation Services

➢ Global Drug Safety Database:

Fully validated database with a client specific schema

3-4 weeks for set-up and testing before going live

PSURs and aggregated reports are produced appropriately

Remote access

Runs directly with annual reports, periodic safety reports

CIOMs and MedWatch reports

➢ Ad-Hoc Listing

➢ Reconciliation of Safety Database and Clinical Database

Pharmacovigilance

ncgs.com

NCGS Inc.

288 Meeting Street Suite 400

Charleston, SC 29401

(843) 722-8330

(866) 541-4042

[email protected]

Corporate Headquarters

Thank you for reviewing this information. Our mission remains to protect research

subjects, capture quality data and maintain the integrity of science with the same

passion one would protect their own domain

Visit www.ncgs.com for additional information

Leadership Team

Nancy C.G. Snowden

CEO & Founder office (843) 722-8330

mobile (843) 670-9555 [email protected]

David McCrary

Director Business Development office (843) 722-8330

mobile (843) 532-4459 [email protected]

Janice Durden

Senior Vice President, Clinical Operations office (843) 722-8330

mobile (843) 568-3621 [email protected]

Alice Baruch, MD Global Medical Director

office (843) 722-8330 [email protected]


Recommended